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New Twists in Gene Regulation Minireview
by Glucocorticoid Receptor:
Is DNA Binding Dispensable?
effect on cooperative binding to palindromic GREs,
but do not completely abolish DNA binding (Dahlman-
Wright et al., 1991).
The view of GR as a ligand-regulated transcription
factor that accomplishes all of its physiological func-
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sion of genes that contain such elements, however,
lasted only until 1990. Although it was realized that GC
can also repress the expression of certain genes, most
Discovered in the1930s inadrenal gland extracts, gluco-
of the attention until that time has focused on positively
corticoid hormones (GCs) were amongst the first steroid
regulated genes. However, in the late 1980s several
hormones to be found. The study of GC action provided groups began to analyze genes that are negatively regu-
many important and critical insights to the mechanisms lated by GC. The first genes subjected to such scrutiny
used by nuclear receptors and other sequence-specific
included those coding for proopiomelanocortin (POMC),
transcription factors to regulate gene transcription. Dur-
the a subunit of glycoprotein hormones, and collagen-
ing the 1970s it was realized that GCs exert their biologi- ase type I. These genes represent important physiologi-
cal effects through a specific receptor, GR, a DNA-bind- cal targets for GC.
ing protein whose nuclear translocation is induced upon In the case of the a subunit gene GC-mediated repres-
ligand binding (Yamamoto, 1985; Beato et al., 1995). sion is caused by interference with the cAMP-respon-
GCs were found to induce transcription of target genes, sive transcription factor CREB (Akerblom et al., 1988),
the most immediate being those whose induction is in- while repression of collagenase transcription was attrib-
sensitive to inhibitors of protein synthesis. Cloning and uted to GR-mediated interference with transcription
analysis of such genes, the murine mammary tumor factor AP-1 (Jonat et al., 1990; Yang-Yen et al., 1990).
virus (MMTV) genome and the human metallothionein AP-1 activity is stimulated by many agonists of which
IIA (hMTIIA) gene, led to identification of the first hormone proinflammatory cytokines are most relevant in this con-
response elements (HREs), in this case called GREs, text. Negative regulation of the POMC gene, on theother
which serve as inducible enhancer elements and GR- hand, is exerted through direct interaction of GR with
binding sites (reviewed by Yamamoto, 1985; Beato et its promoter, which contains a negative GRE (nGRE;
al., 1995). These findings obtained in the early 1980s Drouin et al., 1993). Whereas the exact mechanism by
forged the notion that GR is a sequence-specific ligand- which GR interferes with CREB or AP-1 activity is yet
regulated transcription factor, one of the first eukaryotic to be elucidated, it is almost certain that it does not
transcription factors to be identified. This model was require direct binding to DNA. Mutations within the DBD
considered proven when the GR was molecularly cloned or substitutions of the GR DBD with DBDs of other tran-
and the mechanism by which it activates transcription scription factors do not abolish GR's ability to interfere
of GRE-containing genes was studied indetail (reviewed with AP-1 (Jonat et al., 1990; Yang-Yen et al., 1990).
by Beato et al., 1995). It was even considered that all Importantly, a dimerization-defective GR, generated by
of the physiological effects of GC are mediated through a mutation within the D loop (A458T), does not bind
gene induction (Yamamoto, 1985). Results published in cooperatively to GREs but can still repress AP-1 regu-
this issue of Cell (Reichardt et al., 1998) question lated genes (Heck et al., 1994).
whether DNA binding is required at all for many of the Another transcription factor whose activity is nega-
physiological functions of GR. tively regulated by GC is NF-kB. While transient trans-
Distinct Modes of Transcriptional Control fection experiments suggest that this case of negative
The GR, a prototypical nuclear receptor, is composed regulation is also based on direct interaction between
of three functional domains: a constitutive N-terminal GR and the affected transcription factor, other experi-
activation domain (AF1 or t1), a central DNA-binding ments, some of which were conducted in vivo, indicate
domain (DBD), and a C-terminal ligand-dependent acti- that at least in lymphoid cells the inhibition of NF-kB
vation function (AF2 or t2), a part of the ligand-binding activity by GC is based on induction of IkBa, a specific
domain (Beato et al., 1995). Mutational analysis of GREs NF-kB inhibitor (discussed in Auphan et al., 1995). Al-
revealed them to be palindromic sequences composed though GC stimulate IkBa gene transcription, the GRE
of 6 bp half-sites separated by a 3 bp spacer (Beato et responsible for this effect has not been identified, so
al., 1995). This organization suggests that GR binds such IkBa induction and NF-kB inhibition may not depend on
sites as a dimer. However, it is important to realize that direct binding of GR to DNA. In summary, there are at
the major form of the liganded receptor is monomeric least three major modes through which GC can regulate
in solution and that dimerization occurs only after bind- gene transcription: (1) activation via binding of GR to
ing to palindromic GREs, accounting for cooperative positive GREs; (2) repression via binding of GR to
DNA binding (Dahlman-Wright et al., 1991; Luisi et al., nGREs; and (3) transcriptional interference via interac-
1991). Nevertheless, structural analysis of GR±GRE tions of GR with other transcription factors (Figure 1).
complexes reveals that the D loop within the DBD is Physiological and Pharmacological Actions of GC
responsible for postbinding dimerization (Luisi et al., An extremely important question is which of the many
biological activities of GC are mediated through each1991). Mutations within this region have a devastating
Cell
488
anorexia, nausea, vomiting to the point of dehydration,
and a severe drop in blood pressure leading to shock
or coma (Felig et al., 1987).
There are two major pharmacological uses for GC.
The most obvious one is treatment of adrenocortical
insufficiencies. However GC are more commonly em-
ployed as anti-inflammatory and immunosuppressive
drugs, due to their multiple inhibitory effects on the
immune system. In young mice or rats, administration
of GC causes thymic involution by inducing the apopto-
sis of double positive T cells. However, peripheral lym-
phocytes of both humans and rodents are much less
Figure 1. Mechanism of Transcriptional Regulation by Glucocorti- sensitive to GC-induced lysis and the thymus is not an
coids adult organ. Hence, the far more important anti-inflam-
Typical GR and AP-1 regulated promoters are illustrated as con- matory and immunosuppressive activities of GC are the
taining two GREs or AP-1 sites, although the actual number of inhibition of cytokine gene induction, inhibition of chem-
binding sites can vary from one to several. Interference with AP-1
okine synthesis, and repression of genes encoding cellactivity could be mediated through a direct effect on some aspect
surface receptors and adhesion molecules involved inof AP-1 function or through tethering of GR to AP-1 followed by an
lymphocyte activation, migration, and recruitment. Asinteraction with coactivators or components of the transcriptional
initiation complex (TIC). most of the immunoregulatory genes that are negatively
regulated by GC are positively regulated by AP-1 and
NF-kB, it is quite likely that the immunosuppressive andof these three mechanisms. Before trying to address
anti-inflammatory activities of GC are mediated throughthis question, it is necessary to reviewbriefly GC physiol-
interference with these transcription factors (Barnes andogy and pharmacology. Most illuminating in this respect
Karin, 1997). By contrast, GC-induced T cell lysis isare the symptoms of primary adrenocortical insuffi-
sensitive to inhibition of protein synthesis and thereforeciency, first described by Addison in the mid nineteenth
may depend on gene activation rather than gene re-century as ªgeneral languor and debility, remarkable
pression.feebleness of the heart's action, irritability of the stom-
Although GC are amongst the most potent immuno-ach and a peculiar change in thecolour of the skinº (Felig
suppressive and anti-inflammatory drugs currently avail-et al., 1987). As defined by studies of human patients
able, and are especially efficacious for treatment of dis-and adrenalectomized animals, the most important ac-
eases like asthma and rheumatoid arthritis, there aretions of GC include stimulation of gluconeogenesis, de-
two major problems associated with their prolongedcreased glucose uptake and utilization in peripheral tis-
use. One is their metabolic side effects caused by alter-sues, increased glycogen deposition, increased lipolysis
ations of glucose and lipid metabolism, which can resultand free fatty acid release, stimulation of protein and
in hyperglycemia and decreased carbohydrate toler-nucleic acid synthesis especially in liver, suppression
ance. The second problem is due to decreased collagenof immune and inflammatory responses, inhibition of
and extracellular matrix production by fibroblasts andcytokine synthesis, inhibition of fibroblast prolifera-
enhanced bone resorption, resulting in osteoporosistion and extracellular matrix deposition, maintenance
(Felig et al., 1987). The first problem is caused by theof normal cardiovascular function and blood pressure,
gluconeogenic activity of GC and therefore depends onregulation of calcium absorption and redistribution, ac-
induction of genes such as those for tyrosine amino-celeration of various developmental events, and tissue
transferase (TAT), alanine aminotransferase, and phos-maturation, most notably the liver, pancreas, GI track,
phoenolpyruvate carboxykinase (PEPCK). The regula-and lung (Felig et al., 1987).
tory regions of these genes contain positive GREsWhile these are the general, day-to-day functions of
(Beato et al., 1995). However, the transcriptional mecha-GC, these hormones are especially important for com-
nism underlying the osteolytic activity of GC remainsbating stress. GC synthesis and release are elevated
during stress leading to increased ventricular work load; to be identified. Understanding which transcriptional
mechanism underlies each of the physiological andinhibition of inflammatory mediator and cytokine synthe-
sis; inhibition of vasodilator production; increased glu- pharmacological activities of GC is of great importance,
as it may enable the development of novel GC deriva-cose production; induction of glutamine synthase in the
brain, providing protection from the excitotoxic amino tives that will be able to promote one activity more effi-
ciently than others and thus display increased therapeu-acid glutamate; and induction of metallothionein in the
liver, resulting in chelation of toxic heavy metals (Felig tic value and specificity. For instance, a novel GC was
recently found that is more effective in promoting inter-et al., 1987). As summarized succinctly by Addison, in-
sufficient production of GC results in weakness, weight ference with AP-1 activity than GRE-mediated transacti-
vation (VayssieÂ re et al., 1997). This and similar com-loss, anorexia, gastrointestinal symptoms, such as nau-
sea, abdominal discomfort and vomiting, hyperpigmen- pounds may turn out to be better anti-inflammatory
drugs than the standard GC currently in use.tation, and hypotension. While none of these symptoms
is life threatening, patients suffering from adrenocortical Linking Molecular Mechanisms
to Physiological Functionsinsufficiency are unable to withstand stress and can
suffer an acute adrenal crisis, a critical syndrome in- Given the pleiotropic functions of GC, the plethora of
molecular mechanisms through which they regulateduced by stress. Acute adrenal crisis involves profound
Minireview
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gene transcription, and their extensive clinical use and affected in cells isolated from GRdim/dim mice. However,
the authors have yet to examine this interesting mutantimportance, it is of great interest and relevance to iden-
tify the molecular basis for each of the actions described for regulation of NF-kB activity and repression of NF-
kB dependent target genes.above. A clever new approach to this important problem
is described by Reichardt et al. (1998). Using the latest Given that transcriptional interference is the only regu-
latory function that remains intact in GRdim/dim mice, thetechniques in reversed mouse genetics, the authors
have ªknocked-inº a point mutation into the GR gene obvious question that arises is which of the physiologi-
cal and pharmacological actions of GC are mediatedleading to substitution of alanine 458 by a threonine. As
described above this substitution results in a dimeriza- through this mechanism. However, the curious reader
will have to wait until the GRdim/dim mice are subjected totion-defective GR (GRdim) that no longer binds coopera-
tively to palindromic GREs (Heck et al., 1994). Using more tests and tribulations. For instance, it is likely that
the anti-inflammatory and immunosuppressive activityliver nuclear extracts, Reichardt et al. verify that GRdim/dim
mice no longer express palindromic GRE binding activ- of GC is mostly dependent on interference with AP-1
and NF-kB. Yet the only immune function examined inity. However, they do not exclude the possibility that
GRdim can still bind to GRE halfsites. Nevertheless, using the GRdim/dim mice is GC-induced thymic involution.
Clearly, GRdim/dim mice are fully resistant to GC-inducedtransiently transfected embryonic fibroblast cell lines
and RNA prepared from livers of untreated and GC- killing of double positive thymocytes, and thus this kill-
ing must not necessitate interference with AP-1 activity,injected mice, they do show that GRdim/dim mice no longer
respond to GC with induction of TAT mRNA (Reichardt but rather is likely to relie on binding of GR to GREs.
However, until we know how NF-kB activity is affectedet al., 1998). In addition, there is a large reduction in the
inducibility of an MMTV-based reporter. The residual in GRdim/dim mice, we will have to refrain from judging
whether repression of NF-kB activity is a major contribu-induction is probably due to the fact that GRdim can bind
noncooperatively to the multiple GREs present in the tor to thymocyte killing by GC. In contrast with thymic
involution, GC-mediated killing of human lymphomas,MMTV promoter. Given that these are typical GC-induc-
ible genes, it is safe to assume that GRdim/dim mice are which represents another therapeutic use for GC, does
not seem to require the activating function of GR (Helm-defective by-and-large in mounting a positive transcrip-
tional response to GC. However, some genes containing berg et al., 1995) and may depend on repression of NF-
kB-induced survival factors (Beg and Baltimore, 1996;multiple GREs may be weakly induced, and this could
be physiologically relevant. Liu et al., 1996). Also, the feedback inhibition of GC
secretion mediated via inhibition of corticotropin releas-As GRdim/dim mice appear relatively normal and healthy
under standard laboratory conditions, the most striking ing factor synthesis in the hypothalamus is most likley
based ontranscriptional interference ratherthan bindingoutcome of these experiments is that GRE-mediated
gene activation is not necessary for development and of GR to nGREs, since the circulating levels of GC are
normal in the GRdim/dim mice (Reichardt et al., 1998). Thesurvival. These results are surprising because the same
group had previouslygenerated GR-deficient mice (GR2/2) most interesting question, at least for clinicians and drug
developers, is whether GC administration to GRdim/dimby inactivating the GR gene (Cole et al., 1995). Unlike
the GRdim/dim mice, GR2/2 mice die shortly after birth due mice will result in repression of genes coding for cyto-
kines, chemokines, adhesion molecules, and enzymesto respiratory failure because their lungs have not ma-
tured, lacking surfactant proteins. Clearly, GRE-medi- that produce inflammatory mediators. It is the repres-
sion of such genes that accounts for most of the anti-ated gene induction is not the basis for GC-induced
lung maturation. Although GC are used clinically to in- inflammatory and immunosuppressive activities of GC.
Also of great interest would be how GRdim/dim mice re-duce lung maturation and surfactant expression in hu-
man fetuses expected to be delivered prematurely, no spond to various stresses and whether they display the
same drop in blood pressure as exhibited by patientsfunctional GREs have been described in the promoter
region of any surfactant gene. A common defect for suffering from adrenal crisis. As the ability of GC to
restore blood pressure in such patients is most likelyGR2/2 and GRdim/dim mice is the failure to express glu-
coneogenic enzymes. While these results indicate that mediated through inhibition of prostaglandin and leuko-
triene production (probably through inhibition of cyclo-expression of these enzymes is not necessary for viabil-
ity under standard laboratory conditions, the lesson oxygenase 2 induction, which is likely to be mediated
by interference with AP-1 or NF-kB), it can be expectedlearned from human patients suffering from acute adre-
nal crisis suggests that induction of gluconeogenic en- that as long as GC will exhibit anti-inflammatory activity
in GRdim/dim mice, GC should also be able to maintainzymes may be required for survival under stress. How-
ever, the GRdim/dim mice have not yet been subjected to blood pressure. Thus, GRdim/dim mice may be able to sur-
vive acute stress.a stress test to examine this important point.
In addition to a defect in GRE-mediated gene induc- Although more experiments need to be performed
with these valuable mutant mice before one could reachtion, the GRdim/dim mice are defective in repression of
genes that are regulated through nGREs, exhibiting ele- a sweeping conclusion, I find it difficult to refrain from
speculation: if GRdim/dim mice can survive stress, maybevated expression of POMC and prolactin, two genes
that are controlled by nGREs (Sakai et al., 1988; Drouin the most important functions of GC are not mediated
at all through binding of GR to GREs. If this is indeedet al., 1993). The only transcriptional regulatory function
that is clearly intact in GRdim/dim mice is transcriptional the case, maybe the most important function of GR is
to regulate negatively the activities of AP-1 and NF-kB,interference. Reichardt et al. demonstrate that interfer-
ence with AP-1 activity and repression of AP-1-regu- two transcription factors whose involvement in inflam-
matory responses is evolutionary conserved betweenlated genes, like collagenase and gelatinase, are not
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mammals and insects (Meister et al., 1997). Thus, it is
entirely possible that GC and GR have evolved as nega-
tive regulatory devices that prevent overstimulation and
misfiring of the innate immune system. If this is true,
which function, DNA binding or transcriptional interefer-
ence, evolved first?
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